FATE - Fate Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FATE is currently covered by 8 analysts with an average price target of $11.33. This is a potential upside of $9.87 (676.03%) from yesterday's end of day stock price of $1.46.

Fate Therapeutics's activity chart (see below) currently has 296 price targets and 207 ratings on display. The stock rating distribution of FATE is 60% HOLD and 40% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 59.53% with an average time for these price targets to be met of 144.03 days.

Highest price target for FATE is $7, Lowest price target is $2, average price target is $3.79.

Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 31-Oct-2025.

Currently out of the existing stock ratings of FATE, 6 are a HOLD (60%), 4 are a BUY (40%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 31-Oct-2025

$5

$3.54 (242.47%)

$7

3 months 23 days ago
(31-Oct-2025)

1/5 (20%)

$3.65 (270.37%)

387

Buy Since 27-Oct-2025

$7

$5.54 (379.45%)

$5

3 months 27 days ago
(27-Oct-2025)

8/13 (61.54%)

$5.45 (351.61%)

143

Hold Since 27-Mar-2023

$2.5

$1.04 (71.23%)

$4

6 months 10 days ago
(13-Aug-2025)

2/4 (50%)

$1.37 (121.24%)

49

Buy Since 04-Mar-2020

$2

$0.54 (36.99%)

$10

9 months 9 days ago
(14-May-2025)

6/9 (66.67%)

$1.04 (108.33%)

91

Hold Since 02-Jun-2022

$4

$2.54 (173.97%)

$28

9 months 9 days ago
(14-May-2025)

1/2 (50%)

$3.04 (316.67%)

33

Show more analysts

Please expand the browser size to see the chart

What is FATE (Fate Therapeutics) average time for price targets to be met?

On average it took 144.03 days on average for the stock forecasts to be realized with a an average price target met ratio 59.53

Which analyst has the current highest performing score on FATE (Fate Therapeutics) with a proven track record?

YIGAL NOCHOMOVITZ

Which analyst has the most public recommendations on FATE (Fate Therapeutics)?

Yigal Nochomovitz works at CITI and has 28 price targets and 18 ratings on FATE

Which analyst is the currently most bullish on FATE (Fate Therapeutics)?

Biren Amin with highest potential upside - $107.54

Which analyst is the currently most reserved on FATE (Fate Therapeutics)?

Edward Tenthoff with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?